2026 NPPES data Internal Medicine Physician NPI 1700240215
Verify on CMS →

SAKIBA KHAN

Internal Medicine Physician in BURBANK, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
181
Medicare Part D claims · 94 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$21.66
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SAKIBA KHAN filed 181 Medicare Part D claims in 2023 as a Internal Medicine Physician in BURBANK, California, prescribing 93% generic.

181
Part D claims, 2023
93%
generic prescribing
$21.66
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SAKIBA KHAN's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

181 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

SAKIBA KHAN practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SAKIBA KHAN?

Quality data not reported

NPI registry status

Active

Issued 04/11/2016

NPI 1700240215

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

181 93% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

Specialty distribution in California

How Internal Medicine Physician compares to other specialties among California providers

California providers

Internal Medicine Physician share within California

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Internal Medicine Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Internal Medicine Physician ABMS/AOA estimate

Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SAKIBA KHAN appears in the CMS NPPES registry as a Internal Medicine Physician provider at 4323 W RIVERSIDE DR, BURBANK, CA, 91505, with a listed phone of (818) 556-2700. NPI 1700240215 was issued on 04/11/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KHAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 181 prescription claims written by this provider, covering 94 Medicare beneficiaries and totaling roughly $21K in drug spend, split 7% brand-name and 93% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4323 W RIVERSIDE DR
BURBANK, CA 91505

Provider Details

NPI 1700240215
Specialty Internal Medicine Physician
Gender Female
NPI Issued 04/11/2016

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SAKIBA KHAN. Source: openpaymentsdata.cms.gov.

Total received

$22

Largest payer

Orthofix Medical, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to SAKIBA KHAN. To verify SAKIBA KHAN's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

SAKIBA KHAN — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 181 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

181
Total Claims
$21K
Total Drug Cost
94
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
250
Total Day Supply
7,105
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$3K
Generic Drug Cost
$17K

Patient Demographics

Average Patient Age
63.8 years
Avg HCC Risk Score
1.31
Gender Split
66% female / 34% male
Age Distribution
<65: 34, 65-74: 40, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SAKIBA KHAN prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Buprenorphine-Naloxone
Buprenorphine Hcl/Naloxone Hcl
82
Buprenorphine Hcl
14
Gabapentin
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How SAKIBA KHAN fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

SAKIBA KHAN's 181 claims are below the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as KHAN.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SAKIBA KHAN's specialty?
SAKIBA KHAN specializes in Internal Medicine Physician and practices in BURBANK, California.
How much does SAKIBA KHAN prescribe under Medicare Part D?
In 2023, SAKIBA KHAN wrote 181 Medicare Part D claims totaling $21K in drug costs for 94 beneficiaries.
Where is SAKIBA KHAN located?
SAKIBA KHAN is located at 4323 W RIVERSIDE DR, BURBANK, CA, 91505. Phone: (818) 556-2700.
What is SAKIBA KHAN's NPI number?
SAKIBA KHAN's National Provider Identifier (NPI) is 1700240215, issued on 04/11/2016.
Does SAKIBA KHAN prescribe more brand-name or generic drugs?
SAKIBA KHAN's prescribing is 7% brand-name and 93% generic drugs by claim count, with $3K in brand drug costs.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does SAKIBA KHAN prescribe most often?
Based on 2023 Medicare Part D data, SAKIBA KHAN's most frequently prescribed drugs include Buprenorphine-Naloxone, Buprenorphine Hcl, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SAKIBA KHAN accept Medicare?
SAKIBA KHAN appears in CMS Medicare data with 181 Part D claims and 94 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SAKIBA KHAN's credentials?
SAKIBA KHAN's NPI is 1700240215. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology